triphenyltetrazolium has been researched along with haloperidol in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hashimoto, K; Kirsch, JR; Koehler, RC; London, ED; Takahashi, H; Traystman, RJ | 1 |
1 other study(ies) available for triphenyltetrazolium and haloperidol
Article | Year |
---|---|
PPBP [4-phenyl-1-(4-phenylbutyl) piperidine], a potent sigma-receptor ligand, decreases brain injury after transient focal ischemia in cats.
Topics: Animals; Brain; Cats; Caudate Nucleus; Cerebrovascular Circulation; Evoked Potentials, Somatosensory; Haloperidol; Injections, Intravenous; Ischemic Attack, Transient; Ligands; Neuroprotective Agents; Oxygen Consumption; Parietal Lobe; Receptors, sigma; Reperfusion; Staining and Labeling; Temporal Lobe; Tetrazolium Salts | 1995 |